Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy-Reference-Cited by-同舟云学术

Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy

Published:2022-10 Issue: Volume: Page:
ISSN:2090-1232
Container-title:Journal of Advanced Research
language:en
Short-container-title:Journal of Advanced Research

Author:

Al-Dhfyan Abdullah,Alaiya Ayodele,Al-Mohanna Falah,Attwa Mohamed W^ORCID,AlAsmari Abdullah F,Bakheet Saleh A,Korashy Hesham M.

Funder

King Faisal Specialist Hospital and Research Centre

Qatar University

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference37 articles.

1. Targeting breast cancer stem cells;McDermott;Mol Oncol,2010

2. Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells;Li;BMC cancer,2008

3. Enrichment of cancer stem cells based on the heterogeneity of invasiveness;Yu;Stem cell reviews,2009

4. Stem cells in normal breast development and breast cancer;Dontu;Cell Prolif,2003

5. Stem cells, cancer, and cancer stem cells;Reya;Nature,2001

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aryl hydrocarbon receptor dynamics in esophageal squamous cell carcinoma: From immune modulation to therapeutic opportunities;World Journal of Experimental Medicine;2024-09-20

2. Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells;Exploration of Targeted Anti-tumor Therapy;2024-03-21

3. Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development;Cellular & Molecular Biology Letters;2024-03-06

4. Unveiling the mechanistic role of the Aryl hydrocarbon receptor in environmentally induced Breast cancer;Biochemical Pharmacology;2023-12